Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 85

Related Citations for PubMed (Select 19276166)


Identification of a small molecule class to enhance cell-cell adhesion and attenuate prostate tumor growth and metastasis.

Shah GV, Muralidharan A, Thomas S, Gokulgandhi M, Mudit M, Khanfar M, El Sayed K.

Mol Cancer Ther. 2009 Mar;8(3):509-20. doi: 10.1158/1535-7163.MCT-08-0693. Epub 2009 Mar 10.


Calcitonin promotes in vivo metastasis of prostate cancer cells by altering cell signaling, adhesion, and inflammatory pathways.

Shah GV, Thomas S, Muralidharan A, Liu Y, Hermonat PL, Williams J, Chaudhary J.

Endocr Relat Cancer. 2008 Dec;15(4):953-64. doi: 10.1677/ERC-08-0136. Epub 2008 Sep 10.


Methods for evaluation of structural and biological properties of antiinvasive natural products.

Mudit M, Khanfar M, Shah GV, Sayed KA.

Methods Mol Biol. 2011;716:55-71. doi: 10.1007/978-1-61779-012-6_4.


Knock-down of calcitonin receptor expression induces apoptosis and growth arrest of prostate cancer cells.

Thomas S, Muralidharan A, Shah GV.

Int J Oncol. 2007 Dec;31(6):1425-37.


SKI-606 (Bosutinib) blocks prostate cancer invasion, growth, and metastasis in vitro and in vivo through regulation of genes involved in cancer growth and skeletal metastasis.

Rabbani SA, Valentino ML, Arakelian A, Ali S, Boschelli F.

Mol Cancer Ther. 2010 May;9(5):1147-57. doi: 10.1158/1535-7163.MCT-09-0962. Epub 2010 Apr 27.


High-throughput cell-based screening of 4910 known drugs and drug-like small molecules identifies disulfiram as an inhibitor of prostate cancer cell growth.

Iljin K, Ketola K, Vainio P, Halonen P, Kohonen P, Fey V, Grafström RC, Perälä M, Kallioniemi O.

Clin Cancer Res. 2009 Oct 1;15(19):6070-8. doi: 10.1158/1078-0432.CCR-09-1035. Epub 2009 Sep 29.


Metastatic model for human prostate cancer using orthotopic implantation in nude mice.

Stephenson RA, Dinney CP, Gohji K, Ordóñez NG, Killion JJ, Fidler IJ.

J Natl Cancer Inst. 1992 Jun 17;84(12):951-7.


Small molecule tolfenamic acid inhibits PC-3 cell proliferation and invasion in vitro, and tumor growth in orthotopic mouse model for prostate cancer.

Sankpal UT, Abdelrahim M, Connelly SF, Lee CM, Madero-Visbal R, Colon J, Smith J, Safe S, Maliakal P, Basha R.

Prostate. 2012 Nov;72(15):1648-58. doi: 10.1002/pros.22518. Epub 2012 Apr 2.


Estrogen receptor beta and the progression of prostate cancer: role of 5alpha-androstane-3beta,17beta-diol.

Dondi D, Piccolella M, Biserni A, Della Torre S, Ramachandran B, Locatelli A, Rusmini P, Sau D, Caruso D, Maggi A, Ciana P, Poletti A.

Endocr Relat Cancer. 2010 Jul 28;17(3):731-42. doi: 10.1677/ERC-10-0032. Print 2010 Sep.


Inhibitory effects of antagonists of growth hormone-releasing hormone on growth and invasiveness of PC3 human prostate cancer.

Muñoz-Moreno L, Arenas MI, Schally AV, Fernández-Martínez AB, Zarka E, González-Santander M, Carmena MJ, Vacas E, Prieto JC, Bajo AM.

Int J Cancer. 2013 Feb 15;132(4):755-65. doi: 10.1002/ijc.27716. Epub 2012 Jul 27.


Discovery, design, and synthesis of anti-metastatic lead phenylmethylene hydantoins inspired by marine natural products.

Mudit M, Khanfar M, Muralidharan A, Thomas S, Shah GV, van Soest RW, El Sayed KA.

Bioorg Med Chem. 2009 Feb 15;17(4):1731-8. doi: 10.1016/j.bmc.2008.12.053. Epub 2008 Dec 29. Erratum in: Bioorg Med Chem. 2009 Apr 15;17(8):3216-7.


Roles of vimentin and 14-3-3 zeta/delta in the inhibitory effects of heparin on PC-3M cell proliferation and B16-F10-luc-G5 cells metastasis.

Pan Y, Zhong LJ, Zhou H, Wang X, Chen K, Yang HP, Xiaokaiti Y, Maimaiti A, Jiang L, Li XJ.

Acta Pharmacol Sin. 2012 Jun;33(6):798-808. doi: 10.1038/aps.2012.42.


Selection of highly metastatic variants of different human prostatic carcinomas using orthotopic implantation in nude mice.

Pettaway CA, Pathak S, Greene G, Ramirez E, Wilson MR, Killion JJ, Fidler IJ.

Clin Cancer Res. 1996 Sep;2(9):1627-36.


The prostatic environment suppresses growth of androgen-independent prostate cancer xenografts: an effect influenced by testosterone.

Jennbacken K, Gustavsson H, Tesan T, Horn M, Vallbo C, Welén K, Damber JE.

Prostate. 2009 Aug 1;69(11):1164-75. doi: 10.1002/pros.20965.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk